Phase 3 Readout
BMRN: Phase 3 Topline: A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegva
October 1, 2027 · phenylketonuria-. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 1, 2027
- Company
- BIOMARIN PHARMACEUTICAL INC (BMRN)
- Drug
- phenylketonuria-
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegva
- Drug
- phenylketonuria-
- Indication
- Phenylketonuria (PKU)